Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study
Author(s) -
Sylvie Picard,
H. Hanaire,
Yves Reznik,
PierreYves Benhamou,
S. Fendri,
L. Dufaître,
E. Leutenegger,
Bruno Guerci
Publication year - 2018
Publication title -
diabetes technology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.142
H-Index - 88
eISSN - 1557-8593
pISSN - 1520-9156
DOI - 10.1089/dia.2018.0002
Subject(s) - medicine , diabetes mellitus , continuous glucose monitoring , regimen , term (time) , insulin , type 2 diabetes , type 1 diabetes , endocrinology , intensive care medicine , physics , quantum mechanics
The impact of a 7-day real-time continuous glucose monitoring (RT-CGM) on type 1 diabetes (T1D) management remains unclear in patients suboptimally controlled by multiple daily injections (MDI). The DIACCOR Study aimed to describe treatment decisions and glucose outcomes after a short-term RT-CGM sequence.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom